Attaran Robert R, Edwards Matthew L, Arena Frank J, Bunte Matthew C, Carr Jeffrey G, Castro-Dominguez Yulanka, Espinoza Andrey, Feldman Dmitriy N, Firestone Scott, Fukaya Eri, Harth Karem, Hawkins Beau M, Jayasuriya Sasanka N, Kim Pamela, Latif Faisal, Parikh Sahil A, Secemsky Eric A, Senerth Emily, Falck-Ytter Yngve, Morgan Rebecca L
Yale Heart and Vascular Center, Yale School of Medicine, New Haven, Connecticut.
Cardiology Associates of Michigan, Shelby Township, Michigan.
J Soc Cardiovasc Angiogr Interv. 2025 Jun 30;4(8):103729. doi: 10.1016/j.jscai.2025.103729. eCollection 2025 Aug.
Chronic venous disease (CVD) is a common vascular condition that can have debilitating effects on quality of life and daily function. The Society for Cardiovascular Angiography & Interventions (SCAI) sought to develop evidence-based guidelines to support patients, clinicians, and other stakeholders in their treatment decisions about management of CVD.
SCAI convened a balanced multidisciplinary guideline panel to minimize potential bias from conflicts of interest. The Evidence Foundation, a registered 501(c)(3) nonprofit organization, provided methodological support for the development of the guidelines. The guideline panel formulated and prioritized clinical questions following the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach in population, intervention, comparison, outcome format. A technical review team of clinical and methodological experts conducted systematic reviews of the published evidence, synthesized data, and graded the certainty of the evidence across outcomes. The guideline panel then reconvened to develop recommendations and supporting remarks informed by the results of the technical review, as well as additional contextual factors described in the GRADE evidence-to-decision framework.
The guideline panel reached consensus on 9 recommendations to address variations in treatment of CVD across 8 different clinical scenarios. The panel also identified 4 anatomical scenarios with significant knowledge gaps.
Key recommendations address patient selection for compression therapy, ablation of saphenous and perforator veins, sclerotherapy, phlebectomy, and deep vein revascularization. Two algorithms for the management of symptomatic varicose veins and venous ulcer disease were created to facilitate implementation of these evidence-based recommendations. The panel also identified several anatomical and clinical areas where future research is needed to advance the CVD field.
慢性静脉疾病(CVD)是一种常见的血管疾病,会对生活质量和日常功能产生不利影响。心血管造影与介入学会(SCAI)试图制定基于证据的指南,以支持患者、临床医生和其他利益相关者在CVD管理方面的治疗决策。
SCAI召集了一个平衡的多学科指南小组,以尽量减少利益冲突带来的潜在偏差。证据基金会是一家注册的501(c)(3)非营利组织,为指南的制定提供了方法学支持。指南小组按照推荐分级评估、制定和评价(GRADE)方法,以人群、干预措施、对照、结局的形式制定并确定临床问题的优先级。一个由临床和方法学专家组成的技术审查团队对已发表的证据进行了系统评价,综合了数据,并对各结局证据的确定性进行了分级。然后,指南小组再次召开会议,根据技术审查结果以及GRADE证据到决策框架中描述的其他背景因素,制定建议和支持性说明。
指南小组就9项建议达成共识,以解决8种不同临床场景下CVD治疗的差异。该小组还确定了4个存在重大知识空白的解剖学场景。
关键建议涉及压迫治疗的患者选择、大隐静脉和穿通静脉的消融、硬化疗法、静脉切除术以及深静脉血运重建。创建了两种用于治疗症状性静脉曲张和静脉溃疡疾病的算法,以促进这些基于证据的建议的实施。该小组还确定了几个解剖学和临床领域,未来需要在这些领域开展研究以推动CVD领域的发展。